tert-Butyl 6a-hydroxy-3a,4,6,6a-tetrahydropyrrolo[3,4-c]pyrazole-5(1H)-carboxylate, 97%, 250mg

(R)-4-Fluoro-N-(piperidin-3-yl)benzamidehydrochloride, 95.0%, 1g

N-(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-2-(4-formyl-2-methoxyphenoxy)acetamide, 250mg

(3-(Cyclopentyloxy)-5-methylphenyl)boronic acid, 95.0%, 250mg

(E)-METHYL 3-(3-FLUORO-4-METHYLPHENYL)ACRYLATE, 95.0%, 100mg

(5-Chlorofuran-2-yl)methanamine, 98%, 250mg

(3S,5S)-tert-Butyl 3,5-dimethylpiperazine-1-carboxylate, 95.0%, 500mg

2-(Bromoacetyl)-6-methoxynaphthalene, 95+%, 1g

1,4-butanediol, min 99,0%, pour synthèse, 1L, emballage verre

(S)-1-(4-Bromophenyl)ethanol, 95.0%, 1g

(3-Chloroprop-1-yn-1-yl)benzene, 95.0%, 25g

2-(3-Bromo-phenylsulfanyl)-ethanol, 5g

2-(4-Ethylphenoxy)-N-(4-fluoro-3-nitrophenyl)acetamide, 97.00%, 25mg